Real‐world efficacy of atezolizumab in non‐small cell lung cancer: A multicenter cohort study focused on performance status and retreatment after failure of anti‐PD‐1 antibody
暂无分享,去创建一个
S. Ikeda | Makoto Nishino | N. Furuya | Takashi Sato | K. Wakuda | R. Ushio | Kentaro Ito | S. Tanzawa | M. Sata | K. Ito